Supernatants from cultured tumor tissue specimens activated DRG neurons in vitro and generated somatic nociception in vivo, which was effectively inhibited by the PAR-2 antagonist, FS-NH2, indicating that these effects were PAR-2 dependent. Here, F2RL1 is linked to neoplasm.